Latest News
|
6 August 2012
0 Likes 
Missouri-based KV Pharmaceutical, the manufacturer of pre-term birth prevention compound Makena (hydroprogesterone caproate injection), has filed for bankruptcy in federal court citing the US Food and
Read More...
Latest News
|
26 July 2012
0 Likes
Are the US Food and Drug Administration's (FDA) discretionary enforcement actions beyond industry reproach? In a recent court filing, lawyers for the US regulators argue they are, especially as
Read More...
Latest News
|
6 July 2012
0 Likes
Minneapolis-based K-V Pharmaceutical has a problem: its flagship product, Makena, isn’t maturing into the cash-generating product the company hoped it would become, leaving the company to face likely
Read More...